Страница 1+ · 50 сайта
| NCT00022672 | A Study to Evaluate the Efficacy and Safety of Herceptin® (Trastuzumab) in Combination With Arimidex® (Anastrozole) an Aromatase Inhibitor Compared to Arimidex® Alone in Patients With Metastatic Breast Cancer | COMPLETED | PHASE3 | Hoffmann-La Roche | Breast Cancer | — | Plovdiv | Пловдив |
| NCT00038467 | Randomized Trial Of Exemestane Versus Continued Tamoxifen In Postmenopausal Women With Early Breast Cancer | COMPLETED | PHASE3 | Pfizer | Breast Neoplasms | Pfizer Investigational Site | Plovdiv | Пловдив |
| NCT00043927 | Extensive Small Cell Lung Cancer Treatment Using An Investigational Drug Plus Chemotherapy In Chemotherapy-Naive Adults | COMPLETED | PHASE3 | GlaxoSmithKline | Small Cell Lung Cancer | GSK Clinical Trials Call Center | Plovdiv | Пловдив |
| NCT00046228 | A Study of Abciximab and Reteplase When Administered Prior to Catherization After a Myocardial Infarction (Finesse) | COMPLETED | PHASE3 | Centocor, Inc. | Myocardial Infarction | — | Plovdiv | Пловдив |
| NCT00057304 | Study to Determine the Efficacy, Safety, Tolerability & Pharmacokinetics of RO 205-2349 in Patients With Type 2 Diabetes Mellitus | COMPLETED | PHASE2 | Hoffmann-La Roche | Diabetes | — | Plovdiv | Пловдив |
| NCT00057317 | Study of Ro 205-2349 in Patients With Type 2 Diabetes Mellitus | COMPLETED | PHASE2 | Hoffmann-La Roche | Diabetes | — | Plovdiv | Пловдив |
| NCT00061022 | Safety and Effectiveness of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke | COMPLETED | PHASE3 | AstraZeneca | Cerebral Stroke; Stroke, Acute; Cerebrovascular Stroke; Ischemic Attack, Transient | Research Site | Plovdiv | Пловдив |
| NCT00071799 | A Survival Study in Patients With High Risk Myelodysplastic Syndromes Comparing Azacitidine Versus Conventional Care | COMPLETED | PHASE3 | Celgene | Myelodysplastic Syndromes | III-rd Internal Department, District Dispensary for Oncology diseases with stationary(DDOncDIU) | Plovdiv | Пловдив |
| NCT00071799 | A Survival Study in Patients With High Risk Myelodysplastic Syndromes Comparing Azacitidine Versus Conventional Care | COMPLETED | PHASE3 | Celgene | Myelodysplastic Syndromes | MHAT "St George" Clinic of Hematology, Plovdiv | Plovdiv | Пловдив |
| NCT00073528 | Study Comparing Lapatinib (GW572016) And Letrozole Versus Letrozole In Subjects With Advanced Or Metastatic Breast Cancer | COMPLETED | PHASE3 | Novartis Pharmaceuticals | Breast Neoplasms | Novartis Investigative Site | Plovdiv | Пловдив |
| NCT00086580 | Fludarabine (Fludara®) Plus Alemtuzumab (CAMPATH®, MabCampath®) vs Fludarabine Alone in B-Cell Chronic Lymphocytic Leukemia (B-CLL) Patients | COMPLETED | PHASE3 | Genzyme, a Sanofi Company | B-Cell Chronic Lymphocytic Leukemia | UMHAT St. Georgi, Hematology Clinic | Plovdiv | Пловдив |
| NCT00089804 | Study of LJP 394 in Lupus Patients With History of Renal Disease | TERMINATED | PHASE3 | La Jolla Pharmaceutical Company | Lupus Erythematosus, Systemic; Lupus Nephritis | MHAT "Sveti Georgi", Clinic of Rheumatology | Plovdiv | Пловдив |
| NCT00091442 | A Study of Docetaxel Monotherapy or DOXIL and Docetaxel in Patients With Advanced Breast Cancer | COMPLETED | PHASE3 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Breast Cancer | — | Plovdiv | Пловдив |
| NCT00097344 | The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer | TERMINATED | PHASE3 | Intarcia Therapeutics | Breast Neoplasms; Neoplasms, Hormone-Dependent | Research Site | Plovdiv | Пловдив |
| NCT00099294 | Study of the Efficacy and Safety of Glufosfamide Compared With Best Supportive Care in Metastatic Pancreatic Cancer | COMPLETED | PHASE3 | Threshold Pharmaceuticals | Pancreatic Cancer | First Internal Department Plovdiv Regional Oncology Center with In-patient Department | Plovdiv | Пловдив |
| NCT00102726 | SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adult Cancer Patients Receiving Chemotherapy | COMPLETED | PHASE2 | GlaxoSmithKline | Thrombocytopaenia | GSK Investigational Site | Plovdiv | Пловдив |
| NCT00122811 | The Hypertension in the Very Elderly Trial (HYVET) | UNKNOWN | PHASE4 | Imperial College London | Hypertension | Department of Internal Medicine, Clinic of Rheumatology | Plovdiv | Пловдив |
| NCT00129766 | Study of MEDI-524 (Motavizumab) for the Prophylaxis of Serious Respiratory Syncytial Virus (RSV) Disease in High-Risk Children | COMPLETED | PHASE3 | MedImmune LLC | Respiratory Syncytial Virus Infections | Multifunctional Hospital for Active Treatment - Plovdiv | Plovdiv | Пловдив |
| NCT00129766 | Study of MEDI-524 (Motavizumab) for the Prophylaxis of Serious Respiratory Syncytial Virus (RSV) Disease in High-Risk Children | COMPLETED | PHASE3 | MedImmune LLC | Respiratory Syncytial Virus Infections | University Multifunctional Hospital for Active Treatment "St. George" Clinic of Pediatrics | Plovdiv | Пловдив |
| NCT00129766 | Study of MEDI-524 (Motavizumab) for the Prophylaxis of Serious Respiratory Syncytial Virus (RSV) Disease in High-Risk Children | COMPLETED | PHASE3 | MedImmune LLC | Respiratory Syncytial Virus Infections | University Multifunctional Hospital for Active Treatment "St. George" Neonatology Clinic | Plovdiv | Пловдив |
| NCT00134251 | Ascending Dose Tolerability/Safety of SLV308 for the Treatment of Parkinson's Disease | COMPLETED | PHASE3 | Solvay Pharmaceuticals | Parkinson's Disease | Site 16 | Plovdiv | Пловдив |
| NCT00154102 | Cetuximab Combined With Irinotecan in First-line Therapy for Metastatic Colorectal Cancer (CRYSTAL) | COMPLETED | PHASE3 | Merck KGaA, Darmstadt, Germany | Epidermal Growth Factor Receptor (EGFR) Expressing Metastatic Colorectal Cancer | Research Site | Plovidiv | Пловдив |
| NCT00157339 | Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD | COMPLETED | PHASE3 | Eli Lilly and Company | Diabetes Mellitus; Asthma; Pulmonary Disease, Chronic Obstructive | For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. | Plovdiv | Пловдив |
| NCT00160212 | Study to Evaluate the Efficacy and Safety of SLV306 in Subjects With Hypertension | COMPLETED | PHASE2 | Solvay Pharmaceuticals | Hypertension | Site 956 | Plovdiv | Пловдив |
| NCT00160212 | Study to Evaluate the Efficacy and Safety of SLV306 in Subjects With Hypertension | COMPLETED | PHASE2 | Solvay Pharmaceuticals | Hypertension | Site 951 | Plovdiv | Пловдив |
| NCT00168103 | Human C1 Esterase Inhibitor (C1-INH) in Subjects With Acute Abdominal or Facial Hereditary Angioedema (HAE) Attacks | COMPLETED | PHASE2, PHASE3 | CSL Behring | Hereditary Angioedema | Study Site | Plovdiv | Пловдив |
| NCT00172081 | TOP: Recombinant Human Parathyroid Hormone (ALX1-11) on Fracture Incidence in Women With Postmenopausal Osteoporosis | COMPLETED | PHASE3 | Shire | Osteoporosis | 'Multifunctional Hospital for Active Treatment "Sv.Georgy" | Plovdiv | Пловдив |
| NCT00175903 | Levetiracetam Versus Standard Antiepileptic Drugs (Carbamazepine and Valproate) Used as Monotherapy in Patients With Newly Diagnosed Epilepsy | COMPLETED | PHASE3 | UCB Pharma | Epilepsy | — | Plovdiv | Пловдив |
| NCT00184665 | Comparison of Insulin Detemir With NPH Insulin in Type 1 Diabetes | COMPLETED | PHASE3 | Novo Nordisk A/S | Diabetes; Diabetes Mellitus, Type 1 | Novo Nordisk Investigational Site | Plovdiv | Пловдив |
| NCT00189813 | A Study of YM060 in Diarrhea-predominant Irritable Bowel Syndrome (d-IBS) | COMPLETED | PHASE2 | Astellas Pharma Inc | Irritable Bowel Syndrome | — | Plovdiv | Пловдив |
| NCT00205777 | Study Evaluating Bazedoxifene Acetate In Osteoporosis In Postmenopausal Women | COMPLETED | PHASE3 | Pfizer | Osteoporosis | Pfizer Investigational Site | Plovdiv | Пловдив |
| NCT00205777 | Study Evaluating Bazedoxifene Acetate In Osteoporosis In Postmenopausal Women | COMPLETED | PHASE3 | Pfizer | Osteoporosis | Pfizer Investigational Site | Plovdiv | Пловдив |
| NCT00206167 | A Comparison of Symbicort® pMDI 2 x 160/4.5 μg Bid and 2 x 80/4.5 μg Bid With Formoterol Turbuhaler® 2 x 4.5 μg Bid and Placebo in Patients With COPD | COMPLETED | PHASE3 | AstraZeneca | Chronic Obstructive Pulmonary Disease | Research Site | Plovdiv | Пловдив |
| NCT00206310 | Crestor Versus Placebo in Subjects With Heart Failure | COMPLETED | PHASE3 | AstraZeneca | Heart Failure | Research Site | Plovdiv | Пловдив |
| NCT00216619 | The Prolonged Use of Topiramate for Preventing Migraine Headaches | COMPLETED | PHASE3 | Janssen Pharmaceutica N.V., Belgium | Migraine | — | Plovdiv | Пловдив |
| NCT00224497 | A Dose Ranging Study To Investigate The Efficacy And Safety Of SB-742457 In Alzheimer's Disease | COMPLETED | PHASE2 | GlaxoSmithKline | Alzheimer's Disease | GSK Investigational Site | Plovdiv | Пловдив |
| NCT00239681 | JUPITER - Crestor 20mg Versus Placebo in Prevention of Cardiovascular (CV) Events | TERMINATED | PHASE3 | AstraZeneca | Elevated High-sensitivity C-Reactive Protein (hsCRP) | Research Site | Plovdiv | Пловдив |
| NCT00240331 | AURORA: Crestor 10mg Versus Placebo in Subjects With End-stage Renal Disease (ESRD) | COMPLETED | PHASE3 | AstraZeneca | Renal Failure | Research Site | Plovdiv | Пловдив |
| NCT00242333 | A Study to Assess the Safety and Efficacy of Different AD 237 Doses in Adults With COPD | COMPLETED | PHASE2 | Sosei | COPD | Specialized Hospital for Active Treatment Pneumophthysiatric Disease "Kudoglu" | Plovdiv | Пловдив |
| NCT00242801 | Iressa vs Best Supportive Care - 2nd/3rd Line Survival Study | COMPLETED | PHASE3 | AstraZeneca | NSCLC | Research Site | Plovdiv | Пловдив |
| NCT00256919 | Single Dose Study Of GW856553 On A Protein That Is An Indicator For Rheumatoid Arthritis (RA) | COMPLETED | PHASE2 | GlaxoSmithKline | Arthritis, Rheumatoid | GSK Investigational Site | Plovdiv | Пловдив |
| NCT00257608 | A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS) | COMPLETED | PHASE3 | Genentech, Inc. | Non-Small Cell Lung Cancer | Regional Oncodispensary | Plovdiv | Пловдив |
| NCT00269516 | SLV308 for Treatment of Patients With Early Parkinson's Disease | COMPLETED | PHASE3 | Solvay Pharmaceuticals | Early Stage Parkinson's Disease | Site 107 | Plovdiv | Пловдив |
| NCT00269828 | A Survival Study for Women With Advanced Lung Cancer Who Have Not Previously Received Chemotherapy. | TERMINATED | PHASE3 | CTI BioPharma | NSCLC | District Oncology Dispensary | Plovdiv | Пловдив |
| NCT00274469 | A Clinical Trial to Compare Efficacy and Tolerability of Faslodex With Arimidex in Patients With Advanced Breast Cancer | COMPLETED | PHASE2 | AstraZeneca | Metastatic Breast Cancer | Research Site | Plovdiv | Пловдив |
| NCT00276276 | Active Symptom Control Alone Or In Combination With Oral Topotecan In Patients With Relapsed Resistant Small Cell Lung Cancer | COMPLETED | PHASE3 | GlaxoSmithKline | Lung Cancer, Small Cell | GSK Investigational Site | Plovdiv | Пловдив |
| NCT00280059 | Study Of The Safety And Efficacy Of Lyrica In The Treatment Of Newly Diagnosed Partial Epilepsy | COMPLETED | PHASE3 | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Epilepsy, Partial | Pfizer Investigational Site | Plovdiv | Пловдив |
| NCT00280917 | Oral CF101 and Methotrexate Treatment in Rheumatoid Arthritis Patients | COMPLETED | PHASE2 | Can-Fite BioPharma | Rheumatoid Arthritis | Can-Fite Investigational Site | Plovdiv | Пловдив |
| NCT00288249 | Safety and Efficacy Study of a New Chemotherapy Agent to Treat Metastatic Breast Cancer | COMPLETED | PHASE2 | Bayer | Breast Neoplasms; Breast Cancer, Metastatic | — | Plovdiv | Пловдив |
| NCT00294385 | Study Comparing Concomitant Docetaxel + Gemcitabine to Sequential Therapy of Docetaxel Followed by Gemcitabine | COMPLETED | PHASE3 | Central European Cooperative Oncology Group | Breast Cancer | Cancer Center Plovdiv | Plovdiv | Пловдив |
NCT00022672
A Study to Evaluate the Efficacy and Safety of Herceptin® (Trastuzumab) in Combination With Arimidex® (Anastrozole) an Aromatase Inhibitor Compared to Arimidex® Alone in Patients With Metastatic Breast Cancer
COMPLETEDPHASE3Plovdiv · Пловдив
Breast Cancer
Спонсор: Hoffmann-La Roche
NCT00038467
Randomized Trial Of Exemestane Versus Continued Tamoxifen In Postmenopausal Women With Early Breast Cancer
COMPLETEDPHASE3Plovdiv · Пловдив
Breast Neoplasms
Спонсор: Pfizer
Pfizer Investigational Site
NCT00043927
Extensive Small Cell Lung Cancer Treatment Using An Investigational Drug Plus Chemotherapy In Chemotherapy-Naive Adults
COMPLETEDPHASE3Plovdiv · Пловдив
Small Cell Lung Cancer
Спонсор: GlaxoSmithKline
GSK Clinical Trials Call Center
NCT00046228
A Study of Abciximab and Reteplase When Administered Prior to Catherization After a Myocardial Infarction (Finesse)
COMPLETEDPHASE3Plovdiv · Пловдив
Myocardial Infarction
Спонсор: Centocor, Inc.
NCT00057304
Study to Determine the Efficacy, Safety, Tolerability & Pharmacokinetics of RO 205-2349 in Patients With Type 2 Diabetes Mellitus
COMPLETEDPHASE2Plovdiv · Пловдив
Diabetes
Спонсор: Hoffmann-La Roche
NCT00057317
Study of Ro 205-2349 in Patients With Type 2 Diabetes Mellitus
COMPLETEDPHASE2Plovdiv · Пловдив
Diabetes
Спонсор: Hoffmann-La Roche
NCT00061022
Safety and Effectiveness of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke
COMPLETEDPHASE3Plovdiv · Пловдив
Cerebral Stroke; Stroke, Acute; Cerebrovascular Stroke; Ischemic Attack, Transient
Спонсор: AstraZeneca
Research Site
NCT00071799
A Survival Study in Patients With High Risk Myelodysplastic Syndromes Comparing Azacitidine Versus Conventional Care
COMPLETEDPHASE3Plovdiv · Пловдив
Myelodysplastic Syndromes
Спонсор: Celgene
III-rd Internal Department, District Dispensary for Oncology diseases with stationary(DDOncDIU)
NCT00071799
A Survival Study in Patients With High Risk Myelodysplastic Syndromes Comparing Azacitidine Versus Conventional Care
COMPLETEDPHASE3Plovdiv · Пловдив
Myelodysplastic Syndromes
Спонсор: Celgene
MHAT "St George" Clinic of Hematology, Plovdiv
NCT00073528
Study Comparing Lapatinib (GW572016) And Letrozole Versus Letrozole In Subjects With Advanced Or Metastatic Breast Cancer
COMPLETEDPHASE3Plovdiv · Пловдив
Breast Neoplasms
Спонсор: Novartis Pharmaceuticals
Novartis Investigative Site
NCT00086580
Fludarabine (Fludara®) Plus Alemtuzumab (CAMPATH®, MabCampath®) vs Fludarabine Alone in B-Cell Chronic Lymphocytic Leukemia (B-CLL) Patients
COMPLETEDPHASE3Plovdiv · Пловдив
B-Cell Chronic Lymphocytic Leukemia
Спонсор: Genzyme, a Sanofi Company
UMHAT St. Georgi, Hematology Clinic
NCT00089804
Study of LJP 394 in Lupus Patients With History of Renal Disease
TERMINATEDPHASE3Plovdiv · Пловдив
Lupus Erythematosus, Systemic; Lupus Nephritis
Спонсор: La Jolla Pharmaceutical Company
MHAT "Sveti Georgi", Clinic of Rheumatology
NCT00091442
A Study of Docetaxel Monotherapy or DOXIL and Docetaxel in Patients With Advanced Breast Cancer
COMPLETEDPHASE3Plovdiv · Пловдив
Breast Cancer
Спонсор: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
NCT00097344
The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer
TERMINATEDPHASE3Plovdiv · Пловдив
Breast Neoplasms; Neoplasms, Hormone-Dependent
Спонсор: Intarcia Therapeutics
Research Site
NCT00099294
Study of the Efficacy and Safety of Glufosfamide Compared With Best Supportive Care in Metastatic Pancreatic Cancer
COMPLETEDPHASE3Plovdiv · Пловдив
Pancreatic Cancer
Спонсор: Threshold Pharmaceuticals
First Internal Department Plovdiv Regional Oncology Center with In-patient Department
NCT00102726
SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adult Cancer Patients Receiving Chemotherapy
COMPLETEDPHASE2Plovdiv · Пловдив
Thrombocytopaenia
Спонсор: GlaxoSmithKline
GSK Investigational Site
NCT00122811
The Hypertension in the Very Elderly Trial (HYVET)
UNKNOWNPHASE4Plovdiv · Пловдив
Hypertension
Спонсор: Imperial College London
Department of Internal Medicine, Clinic of Rheumatology
NCT00129766
Study of MEDI-524 (Motavizumab) for the Prophylaxis of Serious Respiratory Syncytial Virus (RSV) Disease in High-Risk Children
COMPLETEDPHASE3Plovdiv · Пловдив
Respiratory Syncytial Virus Infections
Спонсор: MedImmune LLC
Multifunctional Hospital for Active Treatment - Plovdiv
NCT00129766
Study of MEDI-524 (Motavizumab) for the Prophylaxis of Serious Respiratory Syncytial Virus (RSV) Disease in High-Risk Children
COMPLETEDPHASE3Plovdiv · Пловдив
Respiratory Syncytial Virus Infections
Спонсор: MedImmune LLC
University Multifunctional Hospital for Active Treatment "St. George" Clinic of Pediatrics
NCT00129766
Study of MEDI-524 (Motavizumab) for the Prophylaxis of Serious Respiratory Syncytial Virus (RSV) Disease in High-Risk Children
COMPLETEDPHASE3Plovdiv · Пловдив
Respiratory Syncytial Virus Infections
Спонсор: MedImmune LLC
University Multifunctional Hospital for Active Treatment "St. George" Neonatology Clinic
NCT00134251
Ascending Dose Tolerability/Safety of SLV308 for the Treatment of Parkinson's Disease
COMPLETEDPHASE3Plovdiv · Пловдив
Parkinson's Disease
Спонсор: Solvay Pharmaceuticals
Site 16
NCT00154102
Cetuximab Combined With Irinotecan in First-line Therapy for Metastatic Colorectal Cancer (CRYSTAL)
COMPLETEDPHASE3Plovidiv · Пловдив
Epidermal Growth Factor Receptor (EGFR) Expressing Metastatic Colorectal Cancer
Спонсор: Merck KGaA, Darmstadt, Germany
Research Site
NCT00157339
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
COMPLETEDPHASE3Plovdiv · Пловдив
Diabetes Mellitus; Asthma; Pulmonary Disease, Chronic Obstructive
Спонсор: Eli Lilly and Company
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
NCT00160212
Study to Evaluate the Efficacy and Safety of SLV306 in Subjects With Hypertension
COMPLETEDPHASE2Plovdiv · Пловдив
Hypertension
Спонсор: Solvay Pharmaceuticals
Site 956
NCT00160212
Study to Evaluate the Efficacy and Safety of SLV306 in Subjects With Hypertension
COMPLETEDPHASE2Plovdiv · Пловдив
Hypertension
Спонсор: Solvay Pharmaceuticals
Site 951
NCT00168103
Human C1 Esterase Inhibitor (C1-INH) in Subjects With Acute Abdominal or Facial Hereditary Angioedema (HAE) Attacks
COMPLETEDPHASE2, PHASE3Plovdiv · Пловдив
Hereditary Angioedema
Спонсор: CSL Behring
Study Site
NCT00172081
TOP: Recombinant Human Parathyroid Hormone (ALX1-11) on Fracture Incidence in Women With Postmenopausal Osteoporosis
COMPLETEDPHASE3Plovdiv · Пловдив
Osteoporosis
Спонсор: Shire
'Multifunctional Hospital for Active Treatment "Sv.Georgy"
NCT00175903
Levetiracetam Versus Standard Antiepileptic Drugs (Carbamazepine and Valproate) Used as Monotherapy in Patients With Newly Diagnosed Epilepsy
COMPLETEDPHASE3Plovdiv · Пловдив
Epilepsy
Спонсор: UCB Pharma
NCT00184665
Comparison of Insulin Detemir With NPH Insulin in Type 1 Diabetes
COMPLETEDPHASE3Plovdiv · Пловдив
Diabetes; Diabetes Mellitus, Type 1
Спонсор: Novo Nordisk A/S
Novo Nordisk Investigational Site
NCT00189813
A Study of YM060 in Diarrhea-predominant Irritable Bowel Syndrome (d-IBS)
COMPLETEDPHASE2Plovdiv · Пловдив
Irritable Bowel Syndrome
Спонсор: Astellas Pharma Inc
NCT00205777
Study Evaluating Bazedoxifene Acetate In Osteoporosis In Postmenopausal Women
COMPLETEDPHASE3Plovdiv · Пловдив
Osteoporosis
Спонсор: Pfizer
Pfizer Investigational Site
NCT00205777
Study Evaluating Bazedoxifene Acetate In Osteoporosis In Postmenopausal Women
COMPLETEDPHASE3Plovdiv · Пловдив
Osteoporosis
Спонсор: Pfizer
Pfizer Investigational Site
NCT00206167
A Comparison of Symbicort® pMDI 2 x 160/4.5 μg Bid and 2 x 80/4.5 μg Bid With Formoterol Turbuhaler® 2 x 4.5 μg Bid and Placebo in Patients With COPD
COMPLETEDPHASE3Plovdiv · Пловдив
Chronic Obstructive Pulmonary Disease
Спонсор: AstraZeneca
Research Site
NCT00206310
Crestor Versus Placebo in Subjects With Heart Failure
COMPLETEDPHASE3Plovdiv · Пловдив
Heart Failure
Спонсор: AstraZeneca
Research Site
NCT00216619
The Prolonged Use of Topiramate for Preventing Migraine Headaches
COMPLETEDPHASE3Plovdiv · Пловдив
Migraine
Спонсор: Janssen Pharmaceutica N.V., Belgium
NCT00224497
A Dose Ranging Study To Investigate The Efficacy And Safety Of SB-742457 In Alzheimer's Disease
COMPLETEDPHASE2Plovdiv · Пловдив
Alzheimer's Disease
Спонсор: GlaxoSmithKline
GSK Investigational Site
NCT00239681
JUPITER - Crestor 20mg Versus Placebo in Prevention of Cardiovascular (CV) Events
TERMINATEDPHASE3Plovdiv · Пловдив
Elevated High-sensitivity C-Reactive Protein (hsCRP)
Спонсор: AstraZeneca
Research Site
NCT00240331
AURORA: Crestor 10mg Versus Placebo in Subjects With End-stage Renal Disease (ESRD)
COMPLETEDPHASE3Plovdiv · Пловдив
Renal Failure
Спонсор: AstraZeneca
Research Site
NCT00242333
A Study to Assess the Safety and Efficacy of Different AD 237 Doses in Adults With COPD
COMPLETEDPHASE2Plovdiv · Пловдив
COPD
Спонсор: Sosei
Specialized Hospital for Active Treatment Pneumophthysiatric Disease "Kudoglu"
NCT00242801
Iressa vs Best Supportive Care - 2nd/3rd Line Survival Study
COMPLETEDPHASE3Plovdiv · Пловдив
NSCLC
Спонсор: AstraZeneca
Research Site
NCT00256919
Single Dose Study Of GW856553 On A Protein That Is An Indicator For Rheumatoid Arthritis (RA)
COMPLETEDPHASE2Plovdiv · Пловдив
Arthritis, Rheumatoid
Спонсор: GlaxoSmithKline
GSK Investigational Site
NCT00257608
A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS)
COMPLETEDPHASE3Plovdiv · Пловдив
Non-Small Cell Lung Cancer
Спонсор: Genentech, Inc.
Regional Oncodispensary
NCT00269516
SLV308 for Treatment of Patients With Early Parkinson's Disease
COMPLETEDPHASE3Plovdiv · Пловдив
Early Stage Parkinson's Disease
Спонсор: Solvay Pharmaceuticals
Site 107
NCT00269828
A Survival Study for Women With Advanced Lung Cancer Who Have Not Previously Received Chemotherapy.
TERMINATEDPHASE3Plovdiv · Пловдив
NSCLC
Спонсор: CTI BioPharma
District Oncology Dispensary
NCT00274469
A Clinical Trial to Compare Efficacy and Tolerability of Faslodex With Arimidex in Patients With Advanced Breast Cancer
COMPLETEDPHASE2Plovdiv · Пловдив
Metastatic Breast Cancer
Спонсор: AstraZeneca
Research Site
NCT00276276
Active Symptom Control Alone Or In Combination With Oral Topotecan In Patients With Relapsed Resistant Small Cell Lung Cancer
COMPLETEDPHASE3Plovdiv · Пловдив
Lung Cancer, Small Cell
Спонсор: GlaxoSmithKline
GSK Investigational Site
NCT00280059
Study Of The Safety And Efficacy Of Lyrica In The Treatment Of Newly Diagnosed Partial Epilepsy
COMPLETEDPHASE3Plovdiv · Пловдив
Epilepsy, Partial
Спонсор: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Pfizer Investigational Site
NCT00280917
Oral CF101 and Methotrexate Treatment in Rheumatoid Arthritis Patients
COMPLETEDPHASE2Plovdiv · Пловдив
Rheumatoid Arthritis
Спонсор: Can-Fite BioPharma
Can-Fite Investigational Site
NCT00288249
Safety and Efficacy Study of a New Chemotherapy Agent to Treat Metastatic Breast Cancer
COMPLETEDPHASE2Plovdiv · Пловдив
Breast Neoplasms; Breast Cancer, Metastatic
Спонсор: Bayer
NCT00294385
Study Comparing Concomitant Docetaxel + Gemcitabine to Sequential Therapy of Docetaxel Followed by Gemcitabine
COMPLETEDPHASE3Plovdiv · Пловдив
Breast Cancer
Спонсор: Central European Cooperative Oncology Group
Cancer Center Plovdiv
Страница 1+